Pancreatic cancer: two unprecedented advances being tested by scientists

On April 23, 2026, a Franco-Canadian team performed a groundbreaking procedure at CHU Grenoble Alpes by implanting 224 titanium rods containing radium-224 into a pancreatic cancer tumor. This targeted internal irradiation technique aims to limit disease progression. Meanwhile, American laboratory Revolution Medicines is testing a new molecule, daraxonrasib, which targets the KRAS protein, providing new prospects for patients.